Multiple Myeloma
Showing NaN - NaN of 258
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Ixazomib
- +2 more
-
Duarte, California
- +9 more
Jan 11, 2023
Multiple Myeloma Trial in Worldwide (Modakafusp alfa, Lenalidomide, Bortezomib)
Recruiting
- Multiple Myeloma
- Modakafusp alfa
- +5 more
-
Little Rock, Arkansas
- +53 more
Jan 12, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023
Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Whole Foods Plant-based Diet
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Study of CAR-T Therapy in Older Patients
Recruiting
- Lymphoma
- +5 more
- Activities of Daily Living/ADLs
- +10 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
-
Hartford, Connecticut
- +6 more
Jan 3, 2023
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)
Active, not recruiting
- Multiple Myeloma
- daratumumab
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Dec 28, 2022
Multiple Myeloma Trial in United States (Isatuximab, Carfilzomib, Dexamethasone)
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
-
San Francisco, California
- +3 more
Dec 24, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
-
Gilbert, Arizona
- +107 more
Dec 20, 2022
Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +8 more
-
Birmingham, Alabama
- +59 more
Dec 13, 2022
Multiple Myeloma, Lymphoma, Non-Hodgkin's Trial in United States (CFT7455, Dexamethasone Oral)
Recruiting
- Multiple Myeloma
- Lymphoma, Non-Hodgkin's
- CFT7455
- Dexamethasone Oral
-
Phoenix, Arizona
- +12 more
Dec 12, 2022
Multiple Myeloma Trial in United States (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
San Francisco, California
- +5 more
Dec 9, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Birmingham, Alabama
- +25 more
Dec 9, 2022
Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)
Recruiting
- Multiple Myeloma
- TTI-622
- Daratumumab Hyaluronidase-fihj
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
